Your browser doesn't support javascript.
loading
Multifaceted role of dynamin-related protein 1 in cardiovascular disease: From mitochondrial fission to therapeutic interventions.
Kaur, Satinder; Khullar, Naina; Navik, Umashanker; Bali, Anjana; Bhatti, Gurjit Kaur; Bhatti, Jasvinder Singh.
Affiliation
  • Kaur S; Laboratory of Translational Medicine and Nanotherapeutics, Department of Human Genetics and Molecular Medicine, School of Health Sciences, Central University of Punjab, Bathinda India.
  • Khullar N; Department of Zoology, Mata Gujri College, Fatehgarh Sahib, Punjab, India.
  • Navik U; Department of Pharmacology, Central University of Punjab, Ghudda, Bathinda, India.
  • Bali A; Department of Pharmacology, Central University of Punjab, Ghudda, Bathinda, India.
  • Bhatti GK; Department of Medical Lab Technology, University Institute of Applied Health Sciences, Chandigarh University, Mohali India. Electronic address: bhattigk@yahoo.com.
  • Bhatti JS; Laboratory of Translational Medicine and Nanotherapeutics, Department of Human Genetics and Molecular Medicine, School of Health Sciences, Central University of Punjab, Bathinda India. Electronic address: jasvinder.bhatti@cup.edu.in.
Mitochondrion ; 78: 101904, 2024 May 17.
Article in En | MEDLINE | ID: mdl-38763184
ABSTRACT
Mitochondria are central to cellular energy production and metabolic regulation, particularly in cardiomyocytes. These organelles constantly undergo cycles of fusion and fission, orchestrated by key proteins like Dynamin-related Protein 1 (Drp-1). This review focuses on the intricate roles of Drp-1 in regulating mitochondrial dynamics, its implications in cardiovascular health, and particularly in myocardial infarction. Drp-1 is not merely a mediator of mitochondrial fission; it also plays pivotal roles in autophagy, mitophagy, apoptosis, and necrosis in cardiac cells. This multifaceted functionality is often modulated through various post-translational alterations, and Drp-1's interaction with intracellular calcium (Ca2 + ) adds another layer of complexity. We also explore the pathological consequences of Drp-1 dysregulation, including increased reactive oxygen species (ROS) production and endothelial dysfunction. Furthermore, this review delves into the potential therapeutic interventions targeting Drp-1 to modulate mitochondrial dynamics and improve cardiovascular outcomes. We highlight recent findings on the interaction between Drp-1 and sirtuin-3 and suggest that understanding this interaction may open new avenues for therapeutically modulating endothelial cells, fibroblasts, and cardiomyocytes. As the cardiovascular system increasingly becomes the focal point of aging and chronic disease research, understanding the nuances of Drp-1's functionality can lead to innovative therapeutic approaches.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Mitochondrion Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Mitochondrion Year: 2024 Document type: Article